Pharmacological blockade of KV1.3 channel as a promising treatment in autoimmune diseases

There are more than 100 autoimmune diseases (AD), which have a high prevalence that ranges between 5% and 8% of the general population. Type I diabetes mellitus, multiple sclerosis, systemic lupus erythematosus and rheumatoid arthritis remain the health problem of highest concern among people worldw...

Descripción completa

Detalles Bibliográficos
Autores principales: Cañas, Carlos A., Castaño-Valencia, Santiago, Castro-Herrera, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818563/
https://www.ncbi.nlm.nih.gov/pubmed/35146402
http://dx.doi.org/10.1016/j.jtauto.2022.100146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818563/
https://www.ncbi.nlm.nih.gov/pubmed/35146402
http://dx.doi.org/10.1016/j.jtauto.2022.100146

Ejemplares similares